These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3266119)

  • 61. Gluten-sensitive enteropathy. Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to wheat gliadin.
    Weiss JB; Austin RK; Schanfield MS; Kagnoff MF
    J Clin Invest; 1983 Jul; 72(1):96-101. PubMed ID: 6409931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunofluorescent serum gliadin antibodies in children with coeliac disease and various malabsorptive disorders. II. Specificity of Gliadin antibodies: immunoglobulin classes, immunogenic properties of wheat protein fractions, and pathogenic significance of food antibodies in coeliac disease.
    Stern M; Fischer K; Grüttner R
    Eur J Pediatr; 1979 Mar; 130(3):165-72. PubMed ID: 369862
    [No Abstract]   [Full Text] [Related]  

  • 63. Increased peripheral blood CD4+ T cell responses to deamidated but not to native gliadin in children with coeliac disease.
    Lammi A; Arikoski P; Vaarala O; Kinnunen T; Ilonen J
    Clin Exp Immunol; 2012 May; 168(2):207-14. PubMed ID: 22471282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radioimmunoassay for antigliadin-antibodies using 14C-labelled gliadin.
    Menzel J
    J Immunol Methods; 1977; 18(3-4):257-68. PubMed ID: 412899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The lymphocyte transformation test in coeliac disease: effect of gliadin and detoxified gliadin.
    Crowe JP; Phelan JJ; Cleere WF; Fottrell PF; McNicholl B; McCarthy CF
    Digestion; 1980; 20(2):95-9. PubMed ID: 6988261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.
    Koning F; Thomas R; Rossjohn J; Toes RE
    Nat Rev Rheumatol; 2015 Aug; 11(8):450-61. PubMed ID: 25986717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation?
    Biagi F; Ellis HJ; Parnell ND; Shidrawi RG; Thomas PD; O'Reilly N; Corazza GR; Ciclitira PJ
    Aliment Pharmacol Ther; 1999 Jul; 13(7):945-50. PubMed ID: 10383530
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
    Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
    Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Coeliac disease: genetic, immunological and environmental factors in disease pathogenesis.
    Kagnoff MF
    Scand J Gastroenterol Suppl; 1985; 114():45-54. PubMed ID: 3937222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell-mediated immunity to a synthetic gliadin peptide resembling a sequence from adenovirus 12.
    Karagiannis JA; Priddle JD; Jewell DP
    Lancet; 1987 Apr; 1(8538):884-6. PubMed ID: 2882290
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gliadin antibody levels in screening tests for coeliac disease.
    Unsworth DJ; Holborow EJ; Kumar PJ; Ellis A; McConnell RB
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):69-71. PubMed ID: 6418325
    [No Abstract]   [Full Text] [Related]  

  • 72. Coeliac disease--all questions answered?
    Lundin KE
    Dig Liver Dis; 2002 Mar; 34(3):238-42. PubMed ID: 11990398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunoglobulin allotype and serum antigliadin antibodies in coeliac disease.
    Johnson RB; Hetzel PA; LaBrooy JT; Shearman DJ; Davidson GP; Propert DN
    J Gastroenterol Hepatol; 1989; 4(1):115-6. PubMed ID: 2490939
    [No Abstract]   [Full Text] [Related]  

  • 74. Autoantibodies to gliadin-binding 90 kDa glycoprotein in coeliac disease.
    Maury CP; Teppo AM; Vuoristo M; Turunen U; Virtanen I
    Gut; 1986 Feb; 27(2):147-52. PubMed ID: 3485069
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suppressor-cell activity in coeliac disease induced by alpha-gliadin, a dietary antigen.
    O'Farrelly C; Whelan CA; Feighery CF; Weir DG
    Lancet; 1984 Dec; 2(8415):1305-7. PubMed ID: 6150324
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specific Genetic Polymorphisms Contributing in Differential Binding of Gliadin Peptides to HLA-DQ and TCR to Elicit Immunogenicity in Celiac Disease.
    Banerjee P; Chaudhary R; Singh AK; Parulekar P; Kumar S; Senapati S
    Biochem Genet; 2023 Dec; 61(6):2457-2480. PubMed ID: 37103600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism.
    Vojdani A; Pangborn JB; Vojdani E; Cooper EL
    Int J Immunopathol Pharmacol; 2003; 16(3):189-99. PubMed ID: 14611720
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.
    Kagnoff MF; Paterson YJ; Kumar PJ; Kasarda DD; Carbone FR; Unsworth DJ; Austin RK
    Gut; 1987 Aug; 28(8):995-1001. PubMed ID: 2822550
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunopathogenesis of celiac disease.
    Kagnoff MF
    Immunol Invest; 1989; 18(1-4):499-508. PubMed ID: 2659519
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Coeliac Disease and Mast Cells.
    Frossi B; De Carli M; Calabrò A
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31373285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.